The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

J.J. Cornelissen, A. Gratwohl, R.F. Schlenk, J. Sierra, M. Bornhaeuser, G. Juliusson, Z. Racil, J.M. Rowe, N. Russell, M. Mohty, B. Lowenberg, G. Socie, D. Niederwieser, G.J. Ossenkoppele

Research output: Contribution to journalArticleAcademicpeer-review

324 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)579-590
JournalNature Reviews Clinical Oncology
Issue number10
Publication statusPublished - 2012

Cite this